candesartan cilexetil has been researched along with lisinopril in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 8 (66.67) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Funakoshi, J; Kakumoto, M; Okumura, K; Sakaeda, T; Takara, K; Tanigawara, Y | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Kawamura, K; Kubota, J; Mori, T; Nishimura, H; Ueyama, M | 1 |
| Hama, J; Horiuchi, M; Kamoi, K; Katori, R; Kino, H; Nagata, S; Shimada, S; Sugimura, K; Takenaka, T; Yamamoto, Y | 1 |
| Hama, J; Horiuchi, M; Kai, T; Kamoi, K; Kino, H; Nagata, S; Shimada, S; Sugimura, K; Takenaka, T; Yamamoto, Y | 1 |
| Istad, H; Keinänen-Kiukaanniemi, S; McInnes, GT; O'Kane, KP; Van Mierlo, HF | 1 |
| Akao, M; Horie, M; Kouchi, I; Murakami, T; Otani, H; Sakurai, T; Sasayama, S; Takano, M | 1 |
| Chang, CL; Sever, PS | 1 |
| Fujita, M; Hayashi, I; Itoman, M; Majima, M; Yamashina, S | 1 |
| Andersen, NH; Bek, T; Eiskjaer, H; Hansen, KW; Helleberg, K; Knudsen, ST; Mogensen, CE; Poulsen, PL; Poulsen, SH | 1 |
| Fujita, M; Fukamizu, A; Hayashi, I; Itoman, M; Majima, M; Yamashina, S | 1 |
| Geshi, E; Iso, Y; Katagiri, T; Koba, S; Kondo, T; Kusuyama, T; Omori, Y; Sato, T; Shoji, M; Soda, T; Suzuki, H; Tsunoda, F | 1 |
1 review(s) available for candesartan cilexetil and lisinopril
| Article | Year |
|---|---|
Dual blockade with candesartan cilexetil and lisinopril in hypertensive patients with diabetes mellitus: rationale and design.
Topics: Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Diabetes Complications; Drug Therapy, Combination; Humans; Hypertension; Lisinopril; Randomized Controlled Trials as Topic; Tetrazoles | 2003 |
3 trial(s) available for candesartan cilexetil and lisinopril
| Article | Year |
|---|---|
Comparison of the AT1-receptor blocker, candesartan cilexetil, and the ACE inhibitor, lisinopril, in fixed combination with low dose hydrochlorothiazide in hypertensive patients.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Male; Middle Aged; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles; Treatment Outcome | 2000 |
Discordant responses to two classes of drugs acting on the renin-angiotensin system.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cross-Over Studies; Diastole; Double-Blind Method; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Renin; Renin-Angiotensin System; Systole; Tetrazoles | 2001 |
Dual blockade with candesartan cilexetil and lisinopril in hypertensive patients with diabetes mellitus: rationale and design.
Topics: Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Diabetes Complications; Drug Therapy, Combination; Humans; Hypertension; Lisinopril; Randomized Controlled Trials as Topic; Tetrazoles | 2003 |
9 other study(ies) available for candesartan cilexetil and lisinopril
| Article | Year |
|---|---|
Interaction of digoxin with antihypertensive drugs via MDR1.
Topics: Animals; Antihypertensive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cells, Cultured; Digoxin; Drug Interactions; Humans; Time Factors | 2002 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Comparable effects of angiotensin II and converting enzyme blockade on hemodynamics and cardiac hypertrophy in spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Cardiac Output; Cardiomegaly; Heart; Hemodynamics; Hypertension; Kidney; Lisinopril; Male; Organ Size; Rats; Rats, Inbred SHR; Rats, Wistar; Renal Circulation; Tetrazoles | 1995 |
Effect of an angiotensin II receptor antagonist, TCV-116, on rat carotid artery neointimal formation after balloon injury.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Arteriosclerosis; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Carotid Artery Diseases; Carotid Artery, Common; Catheterization; Hypertension; Lisinopril; Male; Prodrugs; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Tetrazoles; Tunica Intima | 1994 |
Effect of an angiotensin II receptor antagonist, TCV-116, on neointimal formation following balloon injury in the SHR carotid artery.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Carotid Arteries; Carotid Artery Injuries; Catheterization; Heart Rate; Lisinopril; Male; Organ Size; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles | 1995 |
Angiotensin II type 1 receptor blockade abolishes specific K(ATP)channel gene expression in rats with myocardial ischemia.
Topics: Angiotensin I; Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Blotting, Northern; Blotting, Western; DNA, Complementary; Lisinopril; Male; Myocardial Ischemia; Myocardium; Natriuretic Peptide, Brain; Potassium Channels; Potassium Channels, Inwardly Rectifying; Random Allocation; Rats; Rats, Wistar; Renin-Angiotensin System; RNA; RNA, Messenger; Tetrazoles; Time Factors; Up-Regulation | 2000 |
Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Antineoplastic Agents; Benzimidazoles; Biphenyl Compounds; Carcinoma, Lewis Lung; Cell Division; Drug Screening Assays, Antitumor; Fibrosarcoma; Immunohistochemistry; Lisinopril; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred ICR; Neoplasm Metastasis; Neoplasm Transplantation; Neovascularization, Pathologic; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Sarcoma 180; Sarcoma, Experimental; Signal Transduction; Tetrazoles | 2002 |
Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Fibroblasts; Lisinopril; Mice; Mice, Inbred ICR; Mice, Knockout; Neovascularization, Pathologic; NF-kappa B; Peptidyl-Dipeptidase A; Protein Kinase C; Receptor, Angiotensin, Type 1; Sarcoma; Signal Transduction; Tetrazoles; Transcription Factor AP-1; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2005 |
Inhibitory effect of candesartan cilexetil on left ventricular remodeling after myocardial infarction.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Enalapril; Female; Humans; Indoles; Lisinopril; Male; Middle Aged; Myocardial Infarction; Tetrazoles; Ventricular Function, Left; Ventricular Remodeling | 2006 |